SAI PARENTERALS: MUMBAI STEP-DOWN SUBSIDIARY ACQUIRES 60% EQUITY STAKE OF PRATHYAK LABORATORIES

• Sai Parenterals Limited completes the acquisition of 60% equity stake in Prathyak Laboratories Private Limited for Rs. 15 crore. • Prathyak Laboratories, an R&D centre, will be renamed Sai Prathyak Laboratories Private Limited and becomes a direct subsidiary. • The acquisition replaces a planned greenfield research centre and has been funded from unutilised IPO proceeds. • Prathyak has 28 research scientists and a pipeline of 150 SKUs across 86 molecules, specializing in complex injectables and oncology. • The residual 40% may be acquired through a Right of First Refusal at the same valuation.

Sai Parenterals Ltd

Open attachment

← Back to feed